HALEY HERNDON: Open Payments
NPI 1508320078 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,759 in 110 payments from 17 companies in 2025. Trend: 2023 $583 · 2024 $1,405 · 2025 $1,759
Food & beverage: $1,692Education: $67
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 14 | $267 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $226 |
| Otsuka America Pharmaceutical, Inc. | 13 | $219 |
| Supernus Pharmaceuticals, Inc. | 15 | $214 |
| E.R. Squibb & Sons, L.L.C. | 12 | $147 |
| ABBVIE INC. | 14 | $137 |
| Lundbeck LLC | 5 | $98 |
| Vanda Pharmaceuticals Inc. | 4 | $96 |
| Janssen Pharmaceuticals, Inc | 5 | $83 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
Products named: CAPLYTA, Qelbree, ARISTADA, COBENFY, VRAYLAR, REXULTI, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across KY — which companies pay providers there.
